Keytruda

All Names： Keytruda，Pembrolizumab

Indications：1.Melanoma; 2. Non-Small Cell Lung Cancer (NSCLC); 3. Head and Neck Squamous Cell Cancer (HNSCC); 4. Classical Hodgkin Lymphoma (cHL); 5. Primary Mediastinal Large B-Cell Lymphoma (PMBCL); 6. Urothelial Carcinoma; 7. Microsatellite Instability-High or Mismatch Repair Deficient Cancer; 8. Microsatellite Instability-High or Mismatch Repair Deficient Colorectal Cancer (CRC); 9. Gastric Cancer; 10. Esophageal Cancer; 11. Cervical Cancer; 12. Hepatocellular Carcinoma (HCC); 13. Merkel Cell Carcinoma (MCC); 14. Renal Cell Carcinoma (RCC); 15. Endometrial Carcinoma; 16. Tumor Mutational Burden-High (TMB-H) Cancer; 17. Cutaneous Squamous Cell Carcinoma (cSCC); 18. Triple-Negative Breast Cancer (TNBC); 19. Adult Indications: Additional Dosing Regimen of 400 mg Every 6 Weeks

Manufacturer：MSD,USA

Customs Clearance Procedure：If the customs requires the package for customs clearance, please pay the customs clearance fee according to the content of EMS SMS and customs regulations.